Previous studies show another DOT1L inhibitor, EPZ004777, also inhibits the proliferation of leukemia cells without an MLL-rearrangement, although to a lesser degree as compared to MLL-rearranged cells [18]. The gene discussed is KMT2A; the disease is leukemia.